1. Home
  2. GHRS vs LDI Comparison

GHRS vs LDI Comparison

Compare GHRS & LDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • LDI
  • Stock Information
  • Founded
  • GHRS 2018
  • LDI 2010
  • Country
  • GHRS Ireland
  • LDI United States
  • Employees
  • GHRS N/A
  • LDI N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • LDI Finance: Consumer Services
  • Sector
  • GHRS Health Care
  • LDI Finance
  • Exchange
  • GHRS Nasdaq
  • LDI Nasdaq
  • Market Cap
  • GHRS 925.2M
  • LDI 221.2M
  • IPO Year
  • GHRS 2021
  • LDI 2021
  • Fundamental
  • Price
  • GHRS $15.58
  • LDI $1.47
  • Analyst Decision
  • GHRS Strong Buy
  • LDI Sell
  • Analyst Count
  • GHRS 8
  • LDI 2
  • Target Price
  • GHRS $30.63
  • LDI $1.98
  • AVG Volume (30 Days)
  • GHRS 187.7K
  • LDI 1.4M
  • Earning Date
  • GHRS 09-02-2025
  • LDI 08-05-2025
  • Dividend Yield
  • GHRS N/A
  • LDI N/A
  • EPS Growth
  • GHRS N/A
  • LDI N/A
  • EPS
  • GHRS N/A
  • LDI N/A
  • Revenue
  • GHRS N/A
  • LDI $1,090,719,000.00
  • Revenue This Year
  • GHRS N/A
  • LDI $28.34
  • Revenue Next Year
  • GHRS N/A
  • LDI $15.10
  • P/E Ratio
  • GHRS N/A
  • LDI N/A
  • Revenue Growth
  • GHRS N/A
  • LDI 21.07
  • 52 Week Low
  • GHRS $6.00
  • LDI $1.01
  • 52 Week High
  • GHRS $20.50
  • LDI $3.23
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 67.14
  • LDI 62.84
  • Support Level
  • GHRS $14.20
  • LDI $1.26
  • Resistance Level
  • GHRS $15.54
  • LDI $1.54
  • Average True Range (ATR)
  • GHRS 1.07
  • LDI 0.09
  • MACD
  • GHRS 0.29
  • LDI 0.01
  • Stochastic Oscillator
  • GHRS 93.84
  • LDI 89.06

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About LDI loanDepot Inc.

loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.

Share on Social Networks: